Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-06 02:10:11 - browse：4289

Maze Therapeutics CEO Jason Coloma Courtesy

After seeing its last deal go bust in the face of regulatory scrutiny, Maze Therapeutics has found another suitor for its experimental Pompe disease treatment.

Bay Area-based Maze and Shionogi said Friday that the Japanese pharma company had licensed the drug, called MZE001, with an upfront payment of $150 million. The global deal includes additional, undisclosed payments if the oral medication, which is in clinical testing, meets certain regulatory and commercial goals.

Last year, Sanofi, the French pharma giant, was set to pay $150 million in cash and stock to Maze before the transaction fell apart.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Elizabeth Warren probes abortion access

WSS

Louisiana bill approved classifying abortion pills as controlled substances

The world needs the new pandemic treaty

New rules on organ donation and transplantation 'will bring chaos'

Guardant Health colon cancer test endorsed by FDA advisory panel

Caitlin Bernard's story shows physicians can't shy from advocacy

Unmasking the 'centricity' illusion in clinical trials

focus

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Russian special forces kill a gunman who broke into a private house near Moscow

Medicare proposal to cover medical devices draws a mixed reaction

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Heart attack and stroke risk calculators need revising

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Bright Health sells Medicare Advantage business to Molina

HIPAA doesn't protect reproductive records from prosecutors

In age of alternative facts, a scholarly course on calling out crap

Organ transplantation is at a crossroads. Major reform is needed

hotspot

Pharma’s losing bet in New Jersey

Should insurance cover cosmetic surgery?

Decentralized clinical trials need collaboration to achieve wider use

Should insurance cover cosmetic surgery?

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

J&J reports mixed data on next

entertainment

Wikipedia

focus

leisure time